ThinkstockInvesting in biotech or biopharmaceutical stocks can prove to be a very daunting task. Many of the stocks have limited pipelines or their very survival depends on a single binary event that…
thinkstockPMI data from Asia shows the slowing of economies there. (Reuters) A private equity buyout of Dell Inc. (NASDAQ: DELL) may be only week away. (Reuters) The cost of beef has squeezed…
Stocks have rallied sharply during January after the last-minute congressional compromise on the fiscal cliff. While the deal was far from perfect, it averted not only a disaster for the U.S. economy,…
U.S. equity markets opened mixed this morning with the DJIA and the S&P 500 higher, and the Nasdaq lower, dragged down by concern over the earnings of Apple Inc. (NASDAQ: AAPL) (more…
U.S. equity markets opened higher this morning following a string of solid earnings reports yesterday and after markets closed last night. As we note below, earnings results were more mixed today, but…
The week ahead will be the official flood gate opening for earnings season. We have a very large portion of the S&P 500 Index reporting fourth-quarter earnings, and we have many Dow Jones…
U.S. equity markets opened flat to lower this morning as the clock ticked down to the final hours in negotiations related to the U.S. fiscal cliff. Share prices edged upward for most…
ThinkstockTeva Pharmaceutical Industries Ltd. (NYSE: TEVA) is not getting any great warm welcome out of its 2012 investor meeting webcast. The company may soon find itself in a position where the turnaround…
U.S. equity markets opened mixed this morning, but some initial enthusiasm wore off by mid-morning and stocks moved slightly lower throughout the day. In Europe, unemployment rose more than expected (more coverage…
These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Friday. Active Network Inc. (NYSE: ACTV) raised to Buy at BofA/ML. Allergan Inc. (NYSE: AGN)…
Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) fell about 80% yesterday after the company revealed that there were discrepancies in the data reported on the company’s Phase II trial of its lung-cancer drug bavituximab.…
Vical Inc. (NASDAQ: VICL) is seeing its shares surging higher on news that it has signed a worldwide, nonexclusive licensing pact with drug giant Bristol-Myers Squibb Co. (NYSE: BMY). The pact covers…
Jon C. Ogg Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday. AngloGold Ashanti Ltd. (NYSE: AU) started as Outperform at Credit Suisse. Apple…
The three major U.S. stock indexes opened lower this morning but picked up some buying steam in the first hour or so of trading. The morning’s report on durable goods sales looked…
Jon OggThese are the top analyst calls of upgrades, downgrades and initiations we have seen from Wall St. research calls this Friday morning. Abercrombie & Fitch Co. (NYSE: ANF) maintained…
